| 标题 |
Corrigendum to ‘Final Analysis Results and Patient-Reported Outcomes From DESTINY-Lung02—A Dose-Blinded, Randomized, Phase 2 Study of Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic NSCLC’ [Journal of Thoracic Oncology Volume 20 Issue 12 (2025) 1814-1828] |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Thoracic Oncology 作者:Pasi A. Jänne; Yasushi Goto; Toshio Kubo; Kiichiro Ninomiya; Sang-We Kim; et al 出版日期:2026-05-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)